...
首页> 外文期刊>Pediatric Research >Treatment of idiopathic growth hormone deficiency: Comparison of growth hormone alone with growth hormone plus thyroxine
【24h】

Treatment of idiopathic growth hormone deficiency: Comparison of growth hormone alone with growth hormone plus thyroxine

机译:治疗特发性生长激素缺乏症:单独使用生长激素与生长激素加甲状腺素的比较

获取原文

摘要

From a series of 36 children with idiopathic hypopituitarism 12 had isolated growth hormone deficiency (IGHD) and 24 multiple pituitary deficiencies (MPHD).9 patients with IGHD on long term treat ment with hGH alone (12.5 U/m2 weekly were compared with 16 MPHD patients receiving T4 substitution (150 μg/m2 daily) in addition.I) Before therapy: a) IGHD: age 7.2,height(SDS) : -3.66;BA (TW-RUS) (SDS) :-2.8; height prediction (TW-RUS age based)(SDS) :-2.67; b) MPHD: age 9.6, height(SDS) :-4.04;BA(SDS) :-3.8; height prediction (SDS) :-2.6.II)Duration of therapy: IGHD:4.8; MPHD : 4.5.III)Height velocities (cm/yr): 1st: IGHD:8.54; MPHD.7.54; 2nd: IGHB 6.59; MPHD 6.96; 3rd: IGHD: 5.68;MPHD:6.89.IV) Bone age progression during total treatment (yr/yr):IGHD 0.95; MPHD:1.09. V) At the end of therapy: a) IGHD:height (SDS): -2.57; prognosis:-1.78, b) MPHD:-2.21, prognosis:-1.44. These results strongly support T4 medication if additional hypothyroidism is suggestive.
机译:在一系列36例特发性垂体功能低下儿童中,有12例患有单独的生长激素缺乏症(IGHD)和24例多发性垂体缺乏症(MPHD)。9例单独接受hGH长期治疗的IGHD患者(每周12.5 U / m2与16例MPHD进行比较) I)治疗前:a)IGHD:7.2岁,身高(SDS):-3.66; BA(TW-RUS)(SDS):-2.8;身高预测(基于TW-RUS年龄)(SDS):-2.67; b)MPHD:年龄9.6,身高(SDS):-4.04; BA(SDS):-3.8;身高预测(SDS):-2.6。II)治疗时间:IGHD:4.8; MPHD:4.5.III)高度速度(cm / yr):1st:IGHD:8.54; MPHD.7.54;第二名:IGHB 6.59; MPHD 6.96;第三位:IGHD:5.68; MPHD:6.89.IV)总体治疗期间的骨龄进展(年/年):IGHD 0.95; MPHD:1.09。 V)在治疗结束时:a)IGHD:身高(SDS):-2.57;预后:-1.78,b)MPHD:-2.21,预后:-1.44。如果提示其他甲状腺功能减退,这些结果强烈支持T4药物治疗。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号